Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Novel platform for investigating quiescence in dormancy-capable cancer cells

A team of researchers from the University of Minnesota-Twin Cities has reported a novel encapsulation approach in identifying dormant cancer cells and maintaining them in a quiescent state.

Their method involves immobilising cells within a rigid silica-PEG matrix that prevents movement and proliferation, thus imposing a selective stress on cells.

Immobilisation within the silica-PEG matrix was performed via a cytocompatible, sol-gel encapsulation method, creating a highly porous matrix with pores large enough to allow sufficient nutrient and gas diffusion to meet metabolic requirements but small enough to prevent cell movement and proliferation.

These findings appear in the journal TECHNOLOGY.

According to Alptekin Aksan, Ph.D., Professor of Mechanical Engineering at the University of Minnesota and senior author on this study, the validation of this model advances the field of study of tumour dormancy as "We know that certain metastases are caused by dormant cells, which are currently impossible to target. If we can isolate and study them, then we can develop ways to destroy them."

Dormant cancer cells undergo quiescent periods during cancer development during which they are not proliferative but remain alive.

Due to their latent nature, they are unresponsive to chemotherapy and responsible for some cases of relapse.

The difficulty in isolating these rare cells from patients has limited understanding of dormancy and the development of therapies to prevent cancer relapse.

Aksan and his team showed in this study that stressing cells by immobilising them in a manner where they cannot proliferate or move leads to a differential response between the cancer cell lines examined.

A fraction of breast cancer cells that normally become dormant in vivo survived in the matrix for up to 3 weeks.

In contrast, other breast cancer cells that are considered more aggressive forms of the disease did not survive in the matrix for more than 24 hrs.

Additionally, researchers showed that noncancerous cells did not survive for long in the gel either.

When cells were extracted from the matrix after 48 hours and returned to favourable growth conditions, cells resumed proliferation.

The preservation of their proliferation potential confirmed that the cellular arrest was reversible as is observed in vivo.

The research team is expected to follow up on this study by using this platform to investigate dormancy in a variety of cancers, particularly those for which the biology of tumour dormancy remains poorly understood.

"This technology is a good starting point for our studies modelling the biologic and mechanical effects of the tumour microenvironment on behaviour of cells that become dormant in cancer patients. Our ultimate goal is to apply this technology in the clinic in order to better predict which individual patient's tumours will be more likely to become dormant, and as a result be more difficult to detect in this patient population," said Aksan. "We are working with physicians as clinical collaborators that provide this clinical perspective to our work."

Source: World Scientific

0

Comments

Please click on the 'New Comment' link to the left to add a new comment, or alternatively click any 'Add Comment' link next to any existing post to respond. The views expressed here are not those of ecancer. For more information please view our Privacy Policy.



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation